| scholarly article | Q13442814 |
| P2093 | author name string | J Kim | |
| X Wu | |||
| J C Kappes | |||
| J A Conway | |||
| P2860 | cites work | Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions | Q24645417 |
| Human immunodeficiency virus vpr product is a virion-associated regulatory protein | Q24649600 | ||
| Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase | Q27860943 | ||
| VPX mutants of HIV-2 are infectious in established cell lines but display a severe defect in peripheral blood lymphocytes | Q33563208 | ||
| Monoclonal antibodies against human immunodeficiency virus (HIV) type 2 core proteins: cross-reactivity with HIV type 1 and simian immunodeficiency virus | Q33649029 | ||
| Gag proteins of the highly replicative MN strain of human immunodeficiency virus type 1: posttranslational modifications, proteolytic processings, and complete amino acid sequences | Q33930053 | ||
| Evolution of the primate lentiviruses: evidence from vpx and vpr | Q33938392 | ||
| The GAG precursor of simian immunodeficiency virus assembles into virus-like particles | Q34046090 | ||
| Genome organization and transactivation of the human immunodeficiency virus type 2. | Q34048704 | ||
| Identification of HIV-1 vpr product and function | Q34168026 | ||
| Human immunodeficiency virus-like particles produced by a vaccinia virus expression vector | Q34320065 | ||
| A virion-specific inhibitory molecule with therapeutic potential for human immunodeficiency virus type 1 | Q36249990 | ||
| Centrophilin: a novel mitotic spindle protein involved in microtubule nucleation | Q36529167 | ||
| Requirement of the Pr55gag precursor for incorporation of the Vpr product into human immunodeficiency virus type 1 viral particles | Q36630330 | ||
| Vpx of simian immunodeficiency virus is localized primarily outside the virus core in mature virions. | Q36650496 | ||
| Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions | Q36654319 | ||
| Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis. | Q36655127 | ||
| Complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: evidence for limited defectiveness and complementation | Q36685254 | ||
| Dispensable role of the human immunodeficiency virus type 2 Vpx protein in viral replication | Q36701891 | ||
| A mutant of human immunodeficiency virus with reduced RNA packaging and abnormal particle morphology | Q36784524 | ||
| Molecular characterization of an attenuated human immunodeficiency virus type 2 isolate | Q36801331 | ||
| Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus | Q36804927 | ||
| Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA. | Q36809360 | ||
| Use of a hybrid vaccinia virus-T7 RNA polymerase system for expression of target genes | Q36843702 | ||
| Identification of a novel retroviral gene unique to human immunodeficiency virus type 2 and simian immunodeficiency virus SIVMAC. | Q36872683 | ||
| Molecular characterization of gag proteins from simian immunodeficiency virus (SIVMne). | Q36877852 | ||
| Distinct signals in human immunodeficiency virus type 1 Pr55 necessary for RNA binding and particle formation | Q38323895 | ||
| RNA packaging signal of human immunodeficiency virus type 1 | Q38328360 | ||
| Mutational analysis of the human immunodeficiency virus vpr open reading frame. | Q40116997 | ||
| HIV-2 viral protein X association with the GAG p27 capsid protein | Q41483290 | ||
| Intracellular transport and virion incorporation of vpx requires interaction with other virus type-specific components. | Q41570102 | ||
| Human immunodeficiency virus type 2 vpx protein augments viral infectivity | Q41667836 | ||
| Human immunodeficiency virus vpr gene encodes a virion-associated protein | Q41716675 | ||
| Production of human immunodeficiency virus (HIV)-like particles from cells infected with recombinant vaccinia viruses carrying the gag gene of HIV | Q41743293 | ||
| Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells | Q42073571 | ||
| A naturally immunogenic virion-associated protein specific for HIV-2 and SIV. | Q42649286 | ||
| Isolation and characterization of a novel protein (X-ORF product) from SIV and HIV-2. | Q42658314 | ||
| Complete nucleotide sequences of functional clones of the AIDS virus | Q45834378 | ||
| Antibody response, recurrence patterns and subsequent herpes simplex virus type 2 (HSV-2) re-infection following initial HSV-2 infection of guinea-pigs: effects of acyclovir | Q45836382 | ||
| Origin of vpx in lentiviruses | Q59096918 | ||
| Form, function, and use of retroviral gag proteins | Q67961638 | ||
| Analysis of retroviral assembly using a vaccinia/T7-polymerase complementation system | Q72967087 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | virology | Q7215 |
| P304 | page(s) | 6161-9 | |
| P577 | publication date | 1994-10-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Localization of the Vpx packaging signal within the C terminus of the human immunodeficiency virus type 2 Gag precursor protein | |
| P478 | volume | 68 |
| Q39823471 | A cellular restriction dictates the permissivity of nondividing monocytes/macrophages to lentivirus and gammaretrovirus infection |
| Q35853370 | A conserved LXXLF sequence is the major determinant in p6gag required for the incorporation of human immunodeficiency virus type 1 Vpr. |
| Q33824939 | A conserved dileucine-containing motif in p6(gag) governs the particle association of Vpx and Vpr of simian immunodeficiency viruses SIV(mac) and SIV(agm) |
| Q45722171 | A non-canonical transferable signal mediates nuclear import of simian immunodeficiency virus Vpx protein. |
| Q50740512 | Analysis of HIV-2 Vpx by modeling and insertional mutagenesis. |
| Q36994727 | Characterization of simian immunodeficiency virus SIVSM/human immunodeficiency virus type 2 Vpx function in human myeloid cells |
| Q38900861 | Degradation of SAMHD1 by Vpx Is Independent of Uncoating |
| Q33926275 | Efficient transduction of myeloid cells by an HIV-1-derived lentiviral vector that packages the Vpx accessory protein |
| Q36484010 | Evidence for Vpr-dependent HIV-1 replication in human CD4+ CEM.NKR T-cells |
| Q33834920 | Functional analysis of the simian immunodeficiency virus Vpx protein: identification of packaging determinants and a novel nuclear targeting domain. |
| Q34033122 | HIV accessory proteins: multifunctional components of a complex system. |
| Q35077587 | Human immunodeficiency virus type 1 modified to package Simian immunodeficiency virus Vpx efficiently infects macrophages and dendritic cells |
| Q39581046 | Human immunodeficiency virus type 2 Vpx-Gag interaction. |
| Q34846363 | Identification of critical regions in human SAMHD1 required for nuclear localization and Vpx-mediated degradation |
| Q40148000 | Impact of viral accessory proteins of SIVsmmPBj on early steps of infection of quiescent cells |
| Q35895836 | Incorporation of functional human immunodeficiency virus type 1 integrase into virions independent of the Gag-Pol precursor protein. |
| Q38716281 | Inhibition of Vpx-Mediated SAMHD1 and Vpr-Mediated Host Helicase Transcription Factor Degradation by Selective Disruption of Viral CRL4 (DCAF1) E3 Ubiquitin Ligase Assembly |
| Q35860937 | Inhibition of human and simian immunodeficiency virus protease function by targeting Vpx-protease-mutant fusion protein into viral particles |
| Q33807088 | Interaction of human immunodeficiency virus type 2 Vpx and invariant chain |
| Q33639651 | Interaction with the p6 domain of the gag precursor mediates incorporation into virions of Vpr and Vpx proteins from primate lentiviruses |
| Q28472652 | Lentiviral Vpx accessory factor targets VprBP/DCAF1 substrate adaptor for cullin 4 E3 ubiquitin ligase to enable macrophage infection |
| Q37728096 | Limelight on two HIV/SIV accessory proteins in macrophage infection: is Vpx overshadowing Vpr? |
| Q35850945 | Mutagenic analysis of human immunodeficiency virus type 1 Vpr: role of a predicted N-terminal alpha-helical structure in Vpr nuclear localization and virion incorporation. |
| Q24684633 | Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr |
| Q33783498 | Mutations of the human immunodeficiency virus type 1 p6Gag domain result in reduced retention of Pol proteins during virus assembly. |
| Q21131105 | New insights into an X-traordinary viral protein |
| Q33721523 | Nonstructural protein 5A is incorporated into hepatitis C virus low-density particle through interaction with core protein and microtubules during intracellular transport |
| Q35914698 | Nuclear import and cell cycle arrest functions of the HIV-1 Vpr protein are encoded by two separate genes in HIV-2/SIV(SM). |
| Q35890940 | Nuclear import, virion incorporation, and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr. |
| Q24624362 | SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates |
| Q24339547 | Structural insight into dGTP-dependent activation of tetrameric SAMHD1 deoxynucleoside triphosphate triphosphohydrolase |
| Q34438247 | Subunit-specific analysis of the human immunodeficiency virus type 1 reverse transcriptase in vivo. |
| Q35839628 | Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx. |
| Q39591808 | The C-terminal proline-rich tail of human immunodeficiency virus type 2 Vpx is necessary for nuclear localization of the viral preintegration complex in nondividing cells |
| Q40084910 | The poly-proline tail of SIVmac Vpx provides gain of function for resistance to a cryptic proteasome-dependent degradation pathway |
| Q41887927 | Variation of two primate lineage-specific residues in human SAMHD1 confers resistance to N terminus-targeted SIV Vpx proteins |
| Q40467618 | Viral Protein X |
| Q34338672 | Viral late domains |
| Q35888756 | Vpr of simian immunodeficiency virus of African green monkeys is required for replication in macaque macrophages and lymphocytes. |
| Q35859146 | Vpr-induced cell cycle arrest is conserved among primate lentiviruses. |
| Q35089155 | Vpx rescues HIV-1 transduction of dendritic cells from the antiviral state established by type 1 interferon |
| Q34288376 | p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease |
Search more.